Financials
- Market Capitalization 468.47 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.57
ratio cours/chiffre d'affaires
22.24
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.69 USD | -0.90% | +6.81% | +21.48% | -19.90% | 474.87 M USD | ||
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.60 USD | +3.23% | -15.79% | -3.61% | -23.08% | 483.30 M USD | ||
| 2987 | SLN Silence Therapeutics Plc - American Depository Share | 10.19 USD | +4.51% | +6.81% | +50.96% | +57.50% | 481.32 M USD | ||
| 2988 | RZLT Rezolute, Inc. - Common Stock | 4.77 USD | -1.24% | -3.05% | +9.66% | -6.47% | 459.31 M USD |